NDC 70518-0223

METHOTREXATE

Methotrexate

METHOTREXATE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Methotrexate Sodium.

Product ID70518-0223_82f56954-66d1-12e3-e053-2a91aa0ad3e7
NDC70518-0223
Product TypeHuman Prescription Drug
Proprietary NameMETHOTREXATE
Generic NameMethotrexate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-02-15
Marketing CategoryNDA / NDA
Application NumberNDA008085
Labeler NameREMEDYREPACK INC.
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength3 mg/1
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-0223-0

30 TABLET in 1 BLISTER PACK (70518-0223-0)
Marketing Start Date2017-02-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0223-2 [70518022302]

METHOTREXATE TABLET
Marketing CategoryNDA
Application NumberNDA008085
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-17
Marketing End Date2019-10-22

NDC 70518-0223-0 [70518022300]

METHOTREXATE TABLET
Marketing CategoryNDA
Application NumberNDA008085
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-15
Marketing End Date2019-02-23

NDC 70518-0223-1 [70518022301]

METHOTREXATE TABLET
Marketing CategoryNDA
Application NumberNDA008085
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-17
Marketing End Date2019-10-03

Drug Details

Active Ingredients

IngredientStrength
METHOTREXATE SODIUM2.5 mg/1

OpenFDA Data

SPL SET ID:a75437f6-65a6-44af-8a2b-47401bff7dc2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 105585
  • Pharmacological Class

    • Folate Analog Metabolic Inhibitor [EPC]
    • Folic Acid Metabolism Inhibitors [MoA]

    NDC Crossover Matching brand name "METHOTREXATE" or generic name "Methotrexate"

    NDCBrand NameGeneric Name
    0143-9367MethotrexateMethotrexate
    0143-9516MethotrexateMethotrexate
    0143-9517MethotrexateMethotrexate
    0143-9518MethotrexateMethotrexate
    0143-9519MethotrexateMethotrexate
    0143-9830MethotrexateMethotrexate
    0378-0014Methotrexatemethotrexate
    0555-0572MethotrexateMethotrexate
    0703-3671MethotrexateMethotrexate
    0703-3675MethotrexateMethotrexate
    0703-3678MethotrexateMethotrexate
    68382-775MethotrexateMethotrexate
    69238-1423MethotrexateMethotrexate
    70518-0223METHOTREXATEMETHOTREXATE
    70518-1251MethotrexateMethotrexate
    70518-1398MethotrexateMethotrexate
    70771-1058MethotrexateMethotrexate
    71335-0782MethotrexateMethotrexate
    16729-277MethotrexateMethotrexate
    21695-111MethotrexateMethotrexate
    42291-594MethotrexateMethotrexate
    42254-110METHOTREXATEMETHOTREXATE
    43063-439MethotrexateMethotrexate
    47335-235MethotrexateMethotrexate
    50090-0294METHOTREXATEMETHOTREXATE
    50090-2345MethotrexateMethotrexate
    50090-3418MethotrexateMethotrexate
    51079-670MethotrexateMethotrexate
    51407-121MethotrexateMethotrexate
    61703-350MethotrexateMethotrexate
    61703-408MethotrexateMethotrexate
    63323-122MethotrexateMethotrexate
    63323-123MethotrexateMethotrexate
    66336-338METHOTREXATEMETHOTREXATE
    67253-320METHOTREXATEMETHOTREXATE
    67457-480MethotrexateMethotrexate
    67457-466MethotrexateMethotrexate
    71335-1118MethotrexateMethotrexate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.